As on (25 Jun 2025 | 22:29)
Back To Homepage As on (25 Jun 2025 | 22:29)
Sun Pharma updates on US FDA inspection Back
(14 Jun 2025)
Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.
Top